ERBB3 and neoplasm: This allows mouse xenograft models of human cancer to be included as appropriate preclinical subjects for evaluating tumor homing in vivo as the particles can be assessed for targeting tumor cells that overexpress HER3 while avoiding normal levels inherent in the mouse despite the capacity to recognize both species of HER3 [22,23].